Related Experiment Video
Updated: Aug 19, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Clinical importance of nuclear progesterone receptor (PR) in endometrial adenocarcinoma
1Department of Gynecology and Obstetrics, University of Ljubljana, Yugoslavia.
Abstract:
Nuclear progesterone receptor (PR) concentrations were measured in 40 samples of endometrial adenocarcinoma and in 13 samples of normal endometrium taken from the same hysterectomy specimen. The levels of PR, expressed in pmol/mg DNA, were correlated with clinical and histopathologic characteristics of endometrial cancer and with the concentrations of progesterone in ovarian blood. The results suggest that PR levels might serve as a additional qualitative and quantitative prognostic risk factor in patients with endometrial cancer.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Abnormal Proliferation
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: